MD - Pediatrix Medical Group reports mixed Q1 earnings; reaffirms FY23 outlook
2023-05-02 06:12:01 ET
- Pediatrix Medical Group press release ( NYSE: MD ): Q1 Non-GAAP EPS of $0.23 beats by $0.01 .
- Revenue of $491M (+1.8% Y/Y) misses by $1.1M .
- Adjusted EBITDA of $40M.
- Pediatrix had cash and cash equivalents of $6.1 million at March 31, 2023, compared to $9.8 million on December 31, 2022, and net accounts receivable was $278.7 million.
- Outlook: As previously disclosed, Pediatrix anticipates that its 2023 Adjusted EBITDA, as defined below, will be in a range of $235 million to $245 million.
For further details see:
Pediatrix Medical Group reports mixed Q1 earnings; reaffirms FY23 outlook